Eastwood Bio-Medical Research Inc.

Eastwood Bio-Medical Research Inc. is a declared insider of Eastwood Bio-Medical Canada Inc., with filings sourced from SEDI. Over a trading history stretching from 30 March 2026 to 6 October 2026, the count stands at 71 filings.

In open-market terms, that means 17 purchases worth €12k on one side and 53 sales worth €153k on the other. The net balance comes to €141k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Half of the purchases are above €605 and half below. Scaled by market value, the purchases weigh a median 0.0008% of market cap (sample: 17 purchases). The 17 purchases reviewed show no overlap with other insiders buying the same stock within a month.

Most recently, on 8 October 2026, the filings show an open-market sale worth €1,363 in Eastwood Bio-Medical Canada Inc. The clock since the last published purchase (8 October 2026) now reads 9 days. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.